|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/22 | |
| C12N 15/11 | |||
| C12N 15/115 |
| (11) | Number of the document | 3054993 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14781175.6 |
| Date of filing the European patent application | 2014-10-06 | |
| (97) | Date of publication of the European application | 2016-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/071343 |
| Date | 2014-10-06 |
| (87) | Number | WO 2015/052133 |
| Date | 2015-04-16 |
| (30) | Number | Date | Country code |
| 102013111099 | 2013-10-08 | DE |
| (72) |
KORMANN, Michael, DE
MAYS, Lauren, DE
LEHR, Claus-Michael, DE
LORETZ, Brigitta, DE
MALAEKSEFAT, Emad, DE
|
| (73) |
Eberhard Karls Universität Tübingen Medizinische Fakultät,
Geschwister-Scholl-Platz, 72074 Tübingen,
DE
Helmholtz-Zentrum für Infektionsforschung GmbH für das Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS, Universität des Saarlandes Pharmazeutische Biotechnologie, 66123 Saarbrücken, DE |
| (54) | PERMANENT GENE CORRECTION BY MEANS OF NUCLEOTIDE-MODIFIED MESSENGER RNA |
| PERMANENT GENE CORRECTION BY MEANS OF NUCLEOTIDE-MODIFIED MESSENGER RNA |